{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:05:47Z","timestamp":1772759147072,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ijantimicag.2005.04.022","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T12:17:48Z","timestamp":1131625068000},"page":"479-485","source":"Crossref","is-referenced-by-count":33,"title":["Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999\u20132003)"],"prefix":"10.1016","volume":"26","author":[{"given":"G.C.","family":"Schito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Felmingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.04.022_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/srin.2000.18059","article-title":"The epidemiology of respiratory tract infections","volume":"15","author":"File","year":"2000","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/srin.2002.31686","article-title":"Update on pneumococcal infections of the respiratory tract","volume":"17","author":"Tan","year":"2002","journal-title":"Semin Respir Infect"},{"issue":"2 Suppl.","key":"10.1016\/j.ijantimicag.2005.04.022_bib3","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1378\/chest.108.2_Supplement.43S","article-title":"Epidemiology and treatment of chronic bronchitis and its exacerbations","volume":"108","author":"Ball","year":"1995","journal-title":"Chest"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2005.04.022_bib4","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/320181","article-title":"Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997\u20131999","volume":"32","author":"Hoban","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"Suppl. S1","key":"10.1016\/j.ijantimicag.2005.04.022_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/dkf808","article-title":"Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin","volume":"50","author":"Felmingham","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kelley","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/313976","article-title":"Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin","volume":"31","author":"Fogarty","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkg116","article-title":"Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams","volume":"51","author":"Van Kerkhoven","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365549850160882","article-title":"Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case\u2013control study","volume":"30","author":"Einarsson","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u20131997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/45.2.191","article-title":"The Alexander Project 1996\u20131997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections","volume":"45","author":"Felmingham","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2005.04.022_bib14","first-page":"3","article-title":"Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin","volume":"44","author":"Felmingham","year":"2002","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib15","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M07-A6. Wayne, PA: CLSI; 2003."},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib16","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. CLSI Document M100-S15. Wayne, PA: CLSI; 2005."},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00006454-199611000-00026","article-title":"Breakthrough sepsis in macrolide-resistant pneumococcal infection","volume":"15","author":"Jackson","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1378\/chest.118.6.1839-a","article-title":"Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy","volume":"118","author":"Waterer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"Musher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.275.3.194","article-title":"Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention","volume":"275","author":"Plouffe","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib22","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/00003495-200262120-00006","article-title":"The ketolides: a critical review","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1742-1241.2003.tb10543.x","article-title":"Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections","volume":"57","author":"Lorenz","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/jac\/dkh339","article-title":"Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides","volume":"54","author":"Drago","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/AAC.44.2.414-417.2000","article-title":"In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae","volume":"44","author":"Davies","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s15010-003-3142-1","article-title":"A pooled analysis of telithromycin in the treatment of community-acquired respiratory tract infections in adults","volume":"31","author":"Carbon","year":"2003","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2005.04.022_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1469-0691.2004.00752.x","article-title":"Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies","volume":"10","author":"Low","year":"2004","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:22:19Z","timestamp":1683282139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905002608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0924857905002608"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.04.022","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}